Danica Holley - Nov 29, 2022 Form 4 Insider Report for THERALINK TECHNOLOGIES, INC. (THER)

Role
Director
Signature
/s/ Danica Holley
Stock symbol
THER
Transactions as of
Nov 29, 2022
Transactions value $
$7,775
Form type
4
Date filed
1/26/2024, 06:28 PM
Previous filing
Jun 22, 2022
Next filing
Feb 24, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction THER 10% O.I.D. Senior Secured Convertible Debenture Other $59.6K $59.6K Nov 29, 2022 Common Stock 19.9M $0.00 Direct F1, F2, F3, F4
transaction THER 8% Convertible Promissory Note Other -$51.8K $0 Nov 29, 2022 Common Stock 10.5M $0.00 Direct F2, F4
transaction THER Common Stock Purchase Warrant Other $0 +17M $0.00 17M Nov 29, 2022 Common Stock 17M $0.00 Direct F1, F2, F3, F5
transaction THER Common Stock Purchase Warrant Other $0 +2.1M $0.00 2.1M Nov 29, 2022 Common Stock 2.1M $0.00 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Assumes a fixed conversion price of $0.003, but such conversion price is subject to adjustment as set forth in the debenture and warrant, respectively.
F2 The Reporting Person was issued a 10% Original Issue Discount ("O.I.D.") Senior Secured Convertible Debenture in the principal amount of $59,604.67 and 17,029,905 warrants in exchange for the 8% Convertible Promissory Note in the principal amount of $51,830 previously issued to the Reporting Person.
F3 The debentures and warrants described in footnote 2 are subject to mandatory conversion upon the occurrence of certain events, as outlined in the debentures and warrants, respectively. The original maturity date of the debentures was subsequently extended to February 29, 2024.
F4 Excludes shares issuable at the election of the Reporting Person upon conversion of accrued interest (both past and future) into shares of common stock.
F5 Expiration Date in the event a Qualified Offering is not consummated prior to the maturity date of the debentures the Warrants are issued in connection with.
F6 In connection with the note exchange describe in footnote 2, the Reporting Person entered into an amendment to its previously issued Common Stock Purchase Warrant amending the exercise price to $0.003 (and subject to adjustment in the event of certain fundamental transactions described in the amended warrant).